Tumor net weights decreased 80.21% (P < 0.001) and 74.83% (P < 0.001) in the si-CCDC150 treatment and gradient RMF exposure groups, respectively, compared to the NC group (Fig. 4H). The gene discussed is CCDC150; the disease is neoplasm.